(Q38048860)

English

Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections

scientific article published on October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1 reference

based on heuristic

inferred from title

Enterobacteriaceae

0 references

Enrico Maria Trecarichi

object named as

Enrico Maria Trecarichi

1

0 references

object named as

Roberto Cauda

2

0 references

Mario Tumbarello

3

object named as

Mario Tumbarello

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

Future Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1173-1189

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Clinical significance of extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

The effect of control group selection in the analysis of risk factors for extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections. A prospective controlled study.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors for bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Extended-spectrum beta-lactamases in long-term-care facilities

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum β-lactamase

1 reference

https://api.crossref.org/works/10.2217%2FFMB.12.100

21 January 2018

Identifiers

10.2217/FMB.12.100

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38048860&oldid=2143491767"